Description
An ASBT inhibitor (IC50s = 42, 2.1, and 1.9 nM for human, mouse, and rat ASBT, respectively); stimulates fecal bile acid secretion, reduces HbA1c and plasma glucose levels, and increases total GLP-1 and plasma insulin levels in ZDF rats,
Formal name: 3-[[[(3R,5R)-3-butyl-3-ethyl-2,3,4,5-tetrahydro-7-methoxy-1,1-dioxido-5-phenyl-1,4-benzothiazepin-8-yl]methyl]amino]-pentanedioic acid
Synonyms:
Molecular weight: 546.7
CAS: 1345982-69-5
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Transporter & Exchanger Modulators||Research Area|Endocrinology & Metabolism|Metabolic Diseases|Diabetes